BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/30/2021 7:03:44 AM | Browse: 745 | Download: 1757
 |
Received |
|
2021-01-18 10:04 |
|
Peer-Review Started |
|
2021-01-18 10:06 |
|
First Decision by Editorial Office Director |
|
2021-02-09 21:07 |
|
Return for Revision |
|
2021-02-09 21:07 |
|
Revised |
|
2021-02-17 07:03 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-03-19 11:21 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-03-19 14:51 |
|
Articles in Press |
|
2021-03-19 14:51 |
|
Edit the Manuscript by Language Editor |
|
2021-03-23 14:35 |
|
Typeset the Manuscript |
|
2021-03-26 07:55 |
|
Publish the Manuscript Online |
|
2021-03-30 07:03 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
COVID-19 and co-morbidities of hepatic diseases in a global perspective
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Aqsa Ahmad, Syeda Momna Ishtiaq, Junaid Ali Khan, Rizwan Aslam, Sultan Ali and Muhammad Imran Arshad |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Muhammad Imran Arshad, PhD, Assistant Professor, Institute of Microbiology, University of Agriculture Faisalabad, Main Agriculture University and Jail Road, Faisalabad 38040, Punjab, Pakistan. drimranarshad@yahoo.com |
| Key Words |
Liver diseases; COVID-19; Pathophysiology; Epidemiology; Prophylaxis |
| Core Tip |
The clinical menace of coronavirus disease 2019 (COVID-19)-related co-morbidities of hepatic diseases and severe acute respiratory syndrome-coronavirus type 2 (SARS-CoV-2) tropism for liver have resulted in liver impairment with increased liver injury markers and cytokine storm. The SARS-CoV-2 aggravates liver injury via coagulative and fibrinolytic pathways, cytokine mediated liver injury, ischemia-hypoxia and immune mediated cell death pathways owing to adverse outcome of liver diseases such as non-alcoholic steatohepatitis, drug-induced liver injuries, non-alcoholic fatty liver disease, metabolic associated fatty liver disease and hepatocellular carcinoma. This review presented diagnostic approaches, therapeutics, clinical guidelines and vaccines for COVID-19 and co-morbidities of liver diseases. |
| Publish Date |
2021-03-30 07:03 |
| Citation |
Ahmad A, Ishtiaq SM, Khan JA, Aslam R, Ali S, Arshad MI. COVID-19 and co-morbidities of hepatic diseases in a global perspective. World J Gastroenterol 2021; 27(13): 1296-1310 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i13/1296.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i13.1296 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
